Studies have demonstrated that MYCL is amplified or highly expressed in the SCLC-A subtype and plays a pivotal role in ASCL1 function, while other subtypes tend to display MYC amplification or overexpression, suggesting that MYC predominates in SCLC with low NE status (13, 69). Here, MYCL is linked to small cell lung carcinoma.